BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab 2020;2:132-41. [PMID: 32694690 DOI: 10.1038/s42255-020-0174-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 32.5] [Reference Citation Analysis]
Number Citing Articles
1 Yin X, Xu R, Song J, Ruze R, Chen Y, Wang C, Xu Q. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Communications. [DOI: 10.1002/cac2.12360] [Reference Citation Analysis]
2 Wang D, Wang F, Kong X, Li Q, Shi H, Zhao S, Li W, Li Y, Meng J. The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention. Biomedicine & Pharmacotherapy 2022;153:113376. [DOI: 10.1016/j.biopha.2022.113376] [Reference Citation Analysis]
3 Abdalkareem Jasim S, Kzar HH, Haider Hamad M, Ahmad I, Al-gazally ME, Ziyadullaev S, Sivaraman R, Abed Jawad M, Thaeer Hammid A, Oudaha KH, Karampoor S, Mirzaei R. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update. International Immunopharmacology 2022;110:109074. [DOI: 10.1016/j.intimp.2022.109074] [Reference Citation Analysis]
4 Feng A, He L, Chen T, Xu M. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer. Front Oncol 2022;12:957966. [DOI: 10.3389/fonc.2022.957966] [Reference Citation Analysis]
5 Zhang L, Chang N, Liu J, Liu Z, Wu Y, Sui L, Chen W. Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy. Front Oncol 2022;12:987499. [DOI: 10.3389/fonc.2022.987499] [Reference Citation Analysis]
6 Wang Q, Cao Y, Shen L, Xiao T, Cao R, Wei S, Tang M, Du L, Wu H, Wu B, Yu Y, Wang S, Wen M, OuYang B. Regulation of PD-L1 through direct binding of cholesterol to CRAC motifs. Sci Adv 2022;8:eabq4722. [PMID: 36026448 DOI: 10.1126/sciadv.abq4722] [Reference Citation Analysis]
7 Wang X, Wang Y, Wang M, Chen X, Cui W, Chen X. The association between serum lipid levels and histological type of breast cancer. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00784-y] [Reference Citation Analysis]
8 Huang Y, Ouyang F, Yang F, Zhang N, Zhao W, Xu H, Yang X. The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma. BMC Cancer 2022;22:900. [PMID: 35982398 DOI: 10.1186/s12885-022-10001-y] [Reference Citation Analysis]
9 Zheng S, Lin J, Pang Z, Zhang H, Wang Y, Ma L, Zhang H, Zhang X, Chen M, Zhang X, Zhao C, Qi J, Cao L, Wang M, He X, Sheng R. Aberrant Cholesterol Metabolism and Wnt/β-Catenin Signaling Coalesce via Frizzled5 in Supporting Cancer Growth. Adv Sci (Weinh) 2022;:e2200750. [PMID: 35975457 DOI: 10.1002/advs.202200750] [Reference Citation Analysis]
10 Wang J, Yan PP, Wang HY, Zuo SJ, Zhang SQ, Cao YX, Cao L. Novel compound ZCJ14, a gefitinib analog, exhibited prominent anti-cancer effect among several cancer cell lines. Life Sci 2022;307:120875. [PMID: 35963298 DOI: 10.1016/j.lfs.2022.120875] [Reference Citation Analysis]
11 Wang Z, Wang M, Zhang M, Xu K, Zhang X, Xie Y, Zhang Y, Chang C, Li X, Sun A, He F. High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth. BMC Med 2022;20:292. [PMID: 35941608 DOI: 10.1186/s12916-022-02436-8] [Reference Citation Analysis]
12 Wei M, Nurjanah U, Herkilini A, Huang C, Li Y, Miyagishi M, Wu S, Kasim V. Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma. Cell Mol Life Sci 2022;79:472. [PMID: 35933495 DOI: 10.1007/s00018-022-04504-x] [Reference Citation Analysis]
13 Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct Target Ther 2022;7:265. [PMID: 35918332 DOI: 10.1038/s41392-022-01125-5] [Reference Citation Analysis]
14 Liu F, Tian T, Zhang Z, Xie S, Yang J, Zhu L, Wang W, Shi C, Sang L, Guo K, Yang Z, Qu L, Liu X, Liu J, Yan Q, Ju HQ, Wang W, Piao HL, Shao J, Zhou T, Lin A. Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma. Nat Metab 2022;4:1022-40. [PMID: 35995997 DOI: 10.1038/s42255-022-00616-7] [Reference Citation Analysis]
15 Wang Y, Kurum A, Tang L. Soft cancer cells squeeze through T cell’s grip. Matter 2022;5:2510-3. [DOI: 10.1016/j.matt.2022.06.041] [Reference Citation Analysis]
16 Anderson J, Walker G, Pu J. BORC-ARL8-HOPS ensemble is required for lysosomal cholesterol egress through NPC2. Mol Biol Cell 2022;33:ar81. [PMID: 35653304 DOI: 10.1091/mbc.E21-11-0595-T] [Reference Citation Analysis]
17 Li Q, Hong J, Feng S, Gong S, Feng G. Polarity-Sensitive Cell Membrane Probe Reveals Lower Polarity of Tumor Cell Membrane and Its Application for Tumor Diagnosis. Anal Chem 2022. [PMID: 35900192 DOI: 10.1021/acs.analchem.2c02312] [Reference Citation Analysis]
18 Ma G, Zhang Z, Li P, Zhang Z, Zeng M, Liang Z, Li D, Wang L, Chen Y, Liang Y, Niu H. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment. Cell Commun Signal 2022;20:114. [PMID: 35897036 DOI: 10.1186/s12964-022-00909-0] [Reference Citation Analysis]
19 Chen H, Zhang J, Sun X, Wang Y, Qian Y. Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma. Front Cell Dev Biol 2022;10:901207. [DOI: 10.3389/fcell.2022.901207] [Reference Citation Analysis]
20 Quan L, Liu Y, Cui W, Wang X, Zhang W, Wang Z, Guo C, Lu C, Hu F, Chen X. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms. Lipids Health Dis 2022;21:58. [PMID: 35842659 DOI: 10.1186/s12944-022-01669-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Luo M, Bao L, Chen Y, Xue Y, Wang Y, Zhang B, Wang C, Corley CD, Mcdonald JG, Kumar A, Xing C, Fang Y, Nelson ER, Wang JE, Wang Y, Luo W. ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells. Sci Adv 2022;8:eabn5295. [DOI: 10.1126/sciadv.abn5295] [Reference Citation Analysis]
22 Lao Y, Li Y, Wang W, Ren L, Qian X, He F, Chen X, Jiang Y. A Cytological Atlas of the Human Liver Proteome from PROTEOMESKY-LIVERHu 2.0, a Publicly Available Database. J Proteome Res 2022. [PMID: 35820117 DOI: 10.1021/acs.jproteome.2c00190] [Reference Citation Analysis]
23 Sánchez-melgar A, Izquierdo-ramírez PJ, Griñán-ferré C, Pallàs M, Martín M, Albasanz JL. Neuroprotective Effects of Resveratrol by Modifying Cholesterol Metabolism and Aβ Processing in SAMP8 Mice. IJMS 2022;23:7580. [DOI: 10.3390/ijms23147580] [Reference Citation Analysis]
24 Nguyen MKL, Jose J, Wahba M, Bernaus-esqué M, Hoy AJ, Enrich C, Rentero C, Grewal T. Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance. IJMS 2022;23:7206. [DOI: 10.3390/ijms23137206] [Reference Citation Analysis]
25 Nie Y, Yun X, Zhang Y, Wang X. Targeting metabolic reprogramming in chronic lymphocytic leukemia. Exp Hematol Oncol 2022;11:39. [PMID: 35761419 DOI: 10.1186/s40164-022-00292-z] [Reference Citation Analysis]
26 Ceja-Vega J, Perez E, Scollan P, Rosario J, Gamez Hernandez A, Ivanchenko K, Gudyka J, Lee S. Trans-Resveratrol Decreases Membrane Water Permeability: A Study of Cholesterol-Dependent Interactions. J Membr Biol 2022. [PMID: 35748919 DOI: 10.1007/s00232-022-00250-0] [Reference Citation Analysis]
27 Zheng Z, Wei Q, Wan X, Zhong X, Liu L, Zeng J, Mao L, Han X, Tou F, Rao J. Correlation Analysis Between Trace Elements and Colorectal Cancer Metabolism by Integrated Serum Proteome and Metabolome. Front Immunol 2022;13:921317. [PMID: 35720415 DOI: 10.3389/fimmu.2022.921317] [Reference Citation Analysis]
28 Yang Z, Tang H, Lu S, Sun X, Rao B. Relationship between serum lipid level and colorectal cancer: a systemic review and meta-analysis. BMJ Open 2022;12:e052373. [PMID: 35732386 DOI: 10.1136/bmjopen-2021-052373] [Reference Citation Analysis]
29 Cui M, Yi X, Zhu D, Wu J. The Role of Lipid Metabolism in Gastric Cancer. Front Oncol 2022;12:916661. [DOI: 10.3389/fonc.2022.916661] [Reference Citation Analysis]
30 Peltomaa AI, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ. Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level. Cancers (Basel) 2022;14:2920. [PMID: 35740586 DOI: 10.3390/cancers14122920] [Reference Citation Analysis]
31 Tsai C, Changchien C, Chen Y, Lai C, Chen T, Chang H, Tsai W, Tsai Y, Tsai H, Lin H, Wang C, Shen M, Lin Y. Survival Benefit of Statin with Anti-Angiogenesis Efficacy in Lung Cancer-Associated Pleural Fluid through FXR Modulation. Cancers 2022;14:2765. [DOI: 10.3390/cancers14112765] [Reference Citation Analysis]
32 Li Q, Xiang M. Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy. Acta Pharmacol Sin 2022;43:1337-48. [PMID: 34561553 DOI: 10.1038/s41401-021-00776-4] [Reference Citation Analysis]
33 Sun H, Meng W, Zhu J, Wang L. Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition. Naunyn Schmiedebergs Arch Pharmacol 2022;395:643-58. [PMID: 35307759 DOI: 10.1007/s00210-022-02200-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Koyiloth M, Gummadi SN. Interaction of human phospholipid scramblase 1 with cholesterol via CRAC motif is essential for functional regulation and subcellular localization. Int J Biol Macromol 2022;209:850-7. [PMID: 35439477 DOI: 10.1016/j.ijbiomac.2022.04.087] [Reference Citation Analysis]
35 Gu X, Zhu Q, Tian G, Song W, Wang T, Wang A, Chen X, Qin S. KIF11 manipulates SREBP2-dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma. Cancer Med 2022. [PMID: 35619540 DOI: 10.1002/cam4.4683] [Reference Citation Analysis]
36 Cheng H, Wang M, Su J, Li Y, Long J, Chu J, Wan X, Cao Y, Li Q. Lipid Metabolism and Cancer. Life 2022;12:784. [DOI: 10.3390/life12060784] [Reference Citation Analysis]
37 Di Maso M, Augustin LSA, Jenkins DJA, Carioli G, Turati F, Grisoni B, Crispo A, La Vecchia C, Serraino D, Polesel J. Adherence to a cholesterol-lowering diet and the risk of prostate cancer. Food Funct 2022;13:5730-8. [PMID: 35522943 DOI: 10.1039/d1fo03795a] [Reference Citation Analysis]
38 Xiao C, Chi Q, Wang X. Recent Progress in Mass Spectrometry-based Metabolomics for Colorectal Cancer. Chem Res Chin Univ . [DOI: 10.1007/s40242-022-2119-5] [Reference Citation Analysis]
39 Raggi C, Taddei ML, Rae C, Braconi C, Marra F. Metabolic Reprogramming in Cholangiocarcinoma. J Hepatol 2022:S0168-8278(22)00314-2. [PMID: 35594992 DOI: 10.1016/j.jhep.2022.04.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Baraniya D, Chitrala KN, Al-hebshi NN. Global transcriptional response of oral squamous cell carcinoma cell lines to health-associated oral bacteria - an in vitro study. Journal of Oral Microbiology 2022;14:2073866. [DOI: 10.1080/20002297.2022.2073866] [Reference Citation Analysis]
41 Göbel A, Riffel RM, Hofbauer LC, Rachner TD. The mevalonate pathway in breast cancer biology. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215761] [Reference Citation Analysis]
42 Qiao Y, Shi Q, Yuan X, Ding J, Li X, Shen M, Huang S, Chen Z, Wang L, Zhao Y, He X. RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma. Cancer Lett 2022;538:215711. [PMID: 35490918 DOI: 10.1016/j.canlet.2022.215711] [Reference Citation Analysis]
43 Xu S, Tang C. Cholesterol and Hedgehog Signaling: Mutual Regulation and Beyond. Front Cell Dev Biol 2022;10:774291. [DOI: 10.3389/fcell.2022.774291] [Reference Citation Analysis]
44 Dehghankelishadi P, Maritz MF, Dmochowska N, Badiee P, Cheah E, Kempson I, Berbeco RI, Thierry B. Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation. J Control Release 2022:S0168-3659(22)00211-5. [PMID: 35447296 DOI: 10.1016/j.jconrel.2022.04.017] [Reference Citation Analysis]
45 Shields CE, Schnepp RW, Haynes KA. Differential Epigenetic Effects of BMI Inhibitor PTC-028 on Fusion-Positive Rhabdomyosarcoma Cell Lines from Distinct Metastatic Sites. Regen Eng Transl Med . [DOI: 10.1007/s40883-021-00244-9] [Reference Citation Analysis]
46 Choi J, Bordeaux ZA, Mckeel J, Nanni C, Sutaria N, Braun G, Davis C, Miller MN, Alphonse MP, Kwatra SG, West CE, Kwatra MM. GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma. IJMS 2022;23:4174. [DOI: 10.3390/ijms23084174] [Reference Citation Analysis]
47 Tu B, Gao Y, Sun F, Shi M, Huang Y. Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity. Front Pharmacol 2022;13:840440. [PMID: 35392570 DOI: 10.3389/fphar.2022.840440] [Reference Citation Analysis]
48 Mabrouk N, Lecoeur B, Bettaieb A, Paul C, Végran F. Impact of Lipid Metabolism on Antitumor Immune Response. Cancers (Basel) 2022;14:1850. [PMID: 35406621 DOI: 10.3390/cancers14071850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Lázaro-Mixteco PE, González-Coronel JM, Hernández-Padilla L, Martínez-Alcantar L, Martínez-Carranza E, López-Bucio JS, Guevara-García ÁA, Campos-García J. Transcriptomics Reveals the Mevalonate and Cholesterol Pathways Blocking as Part of the Bacterial Cyclodipeptides Cytotoxic Effects in HeLa Cells of Human Cervix Adenocarcinoma. Front Oncol 2022;12:790537. [PMID: 35359411 DOI: 10.3389/fonc.2022.790537] [Reference Citation Analysis]
50 Peng Y, Cong Y, Lei Y, Sun F, Xu M, Zhang J, Fang L, Hong H, Cai T. Transforming Passive into Active: Multimodal Pheophytin-Based Carbon Dots Customize Protein Corona to Target Metastatic Breast Cancer. Adv Healthc Mater 2022;11:e2102270. [PMID: 35032116 DOI: 10.1002/adhm.202102270] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Rebhahn VIC, Kiss E, Marko D, Del Favero G. Foodborne compounds that alter plasma membrane architecture can modify the response of intestinal cells to shear stress in vitro. Toxicology and Applied Pharmacology 2022. [DOI: 10.1016/j.taap.2022.116034] [Reference Citation Analysis]
52 Liou JW, Mani H, Yen JH. Viral Hepatitis, Cholesterol Metabolism, and Cholesterol-Lowering Natural Compounds. Int J Mol Sci 2022;23:3897. [PMID: 35409259 DOI: 10.3390/ijms23073897] [Reference Citation Analysis]
53 Tőkés AM, Vári-kakas S, Kulka J, Törőcsik B. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas. Front Oncol 2022;12:850401. [DOI: 10.3389/fonc.2022.850401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Laka K, Makgoo L, Mbita Z. Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions. Front Genet 2022;13:841639. [DOI: 10.3389/fgene.2022.841639] [Reference Citation Analysis]
55 Bai M, Sun C. Determination of Breast Metabolic Phenotypes and Their Associations With Immunotherapy and Drug-Targeted Therapy: Analysis of Single-Cell and Bulk Sequences. Front Cell Dev Biol 2022;10:829029. [PMID: 35281118 DOI: 10.3389/fcell.2022.829029] [Reference Citation Analysis]
56 Prendeville H, Lynch L. Diet, lipids, and antitumor immunity. Cell Mol Immunol 2022;19:432-44. [PMID: 34983949 DOI: 10.1038/s41423-021-00781-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
57 Kosaka S, Miyashita M, Mcnamala K, Nomura M, Shima H, Kawai M, Sato I, Shoji-harada N, Ishida T, Choi MH, Sasano H. Bird’s eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes. The Journal of Steroid Biochemistry and Molecular Biology 2022. [DOI: 10.1016/j.jsbmb.2022.106103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wang SY, Hu QC, Wu T, Xia J, Tao XA, Cheng B. Abnormal lipid synthesis as a therapeutic target for cancer stem cells. World J Stem Cells 2022; 14(2): 146-162 [DOI: 10.4252/wjsc.v14.i2.146] [Reference Citation Analysis]
59 Banyś K, Stawarska A, Wyrębiak R, Bielecki W, Bobrowska-Korczak B. The Effect of Genistein Supplementation on Cholesterol Oxidation Products and Fatty Acid Profiles in Serums of Rats with Breast Cancer. Foods 2022;11:605. [PMID: 35206081 DOI: 10.3390/foods11040605] [Reference Citation Analysis]
60 Fan K, Liu Z, Gao M, Tu K, Xu Q, Zhang Y. Targeting Nutrient Dependency in Cancer Treatment. Front Oncol 2022;12:820173. [PMID: 35178349 DOI: 10.3389/fonc.2022.820173] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Pardo JC, Ruiz de Porras V, Gil J, Font A, Puig-domingo M, Jordà M. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients 2022;14:851. [DOI: 10.3390/nu14040851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Iatridis N, Kougioumtzi A, Vlataki K, Papadaki S, Magklara A. Anti-Cancer Properties of Stevia rebaudiana; More than a Sweetener. Molecules 2022;27:1362. [PMID: 35209150 DOI: 10.3390/molecules27041362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
63 Kelemen A, Carmi I, Seress I, Lőrincz P, Tölgyes T, Dede K, Bursics A, Buzás EI, Wiener Z. CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity. Int J Mol Sci 2022;23:2180. [PMID: 35216292 DOI: 10.3390/ijms23042180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Deng C, Zhu N, Zhao T, Li H, Gu J, Liao D, Qin L. Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential. Front Oncol 2022;12:803473. [DOI: 10.3389/fonc.2022.803473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
65 Liu Z, Gomez CR, Espinoza I, Le TPT, Shenoy V, Zhou X. Correlation of cholesteryl ester metabolism to pathogenesis, progression and disparities in colorectal Cancer. Lipids Health Dis 2022;21:22. [PMID: 35172832 DOI: 10.1186/s12944-022-01629-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Vuong JT, Stein-Merlob AF, Nayeri A, Sallam T, Neilan TG, Yang EH. Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review. J Am Coll Cardiol 2022;79:577-93. [PMID: 35144750 DOI: 10.1016/j.jacc.2021.11.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
67 Kovacs T, Zakany F, Nagy P. It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases. Cancers (Basel) 2022;14:944. [PMID: 35205690 DOI: 10.3390/cancers14040944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
68 Benitez-amaro A, Martínez-bosch N, Manero-rupérez N, Claudi L, La Chica Lhoëst MT, Soler M, Ros-blanco L, Navarro P, Llorente-cortés V. Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells. Cancers 2022;14:890. [DOI: 10.3390/cancers14040890] [Reference Citation Analysis]
69 Chen YY, Ge JY, Zhu SY, Shao ZM, Yu KD. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis. Nat Commun 2022;13:791. [PMID: 35145111 DOI: 10.1038/s41467-022-28452-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Cui MY, Yi X, Zhu DX, Wu J. Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review. Transl Cancer Res 2021;10:3829-42. [PMID: 35116681 DOI: 10.21037/tcr-21-655] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Yuan Y, Li H, Pu W, Chen L, Guo D, Jiang H, He B, Qin S, Wang K, Li N, Feng J, Wen J, Cheng S, Zhang Y, Yang W, Ye D, Lu Z, Huang C, Mei J, Zhang HF, Gao P, Jiang P, Su S, Sun B, Zhao SM. Cancer metabolism and tumor microenvironment: fostering each other? Sci China Life Sci 2022;65:236-79. [PMID: 34846643 DOI: 10.1007/s11427-021-1999-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
72 Wen Tan SL, Israeli E, Ericksen RE, Chow PK, Han W. The altered lipidome of hepatocellular carcinoma. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Kanmalar M, Abdul Sani SF, Kamri NINB, Said NABM, Jamil AHBA, Kuppusamy S, Mun KS, Bradley DA. Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review. Cell Mol Biol Lett 2022;27. [DOI: 10.1186/s11658-022-00307-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
74 Zhou S, He Q, Sheng N, Gong J, Ren J, Wang Z. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer. World J Surg Oncol 2022;20:18. [PMID: 35033097 DOI: 10.1186/s12957-021-02471-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Zhang F, Macshane B, Searcy R, Huang Z. Mathematical Models for Cholesterol Metabolism and Transport. Processes 2022;10:155. [DOI: 10.3390/pr10010155] [Reference Citation Analysis]
76 Stolzenburg LR, Ainsworth B, Riley-Gillis B, Pakozdi T, Ammar A, Ellis PA, Wilsbacher JL, Ramathal CY. Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models. Oncotarget 2022;13:1-12. [PMID: 35018214 DOI: 10.18632/oncotarget.28162] [Reference Citation Analysis]
77 Wu X, Yan R, Cao P, Qian H, Yan N. Structural advances in sterol-sensing domain-containing proteins. Trends Biochem Sci 2022:S0968-0004(21)00274-7. [PMID: 35012873 DOI: 10.1016/j.tibs.2021.12.005] [Reference Citation Analysis]
78 Katakam S, Anand S, Martin P, Riggi N, Stamenkovic I. Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis. Life Sci Alliance 2022;5:e202101256. [PMID: 34983824 DOI: 10.26508/lsa.202101256] [Reference Citation Analysis]
79 Wang Y, Wang Z, Sun J, Qian Y. Identification of HCC Subtypes With Different Prognosis and Metabolic Patterns Based on Mitophagy. Front Cell Dev Biol 2021;9:799507. [PMID: 34977039 DOI: 10.3389/fcell.2021.799507] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
80 Zhang Y, Zhu B, Cai Y, Zhu S, Zhao H, Ying X, Jiang C, Zeng J. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration. BMC Cancer 2022;22:2. [PMID: 34980012 DOI: 10.1186/s12885-021-09064-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
81 King RJ, Singh PK, Mehla K. The cholesterol pathway: impact on immunity and cancer. Trends in Immunology 2022;43:78-92. [DOI: 10.1016/j.it.2021.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
82 You JS, Lim H, Seo JY, Kang KR, Kim DK, Oh JS, Seo YS, Lee GJ, Kim JS, Kim HJ, Yu SK, Kim JS. 25-Hydroxycholesterol-Induced Oxiapoptophagy in L929 Mouse Fibroblast Cell Line. Molecules 2021;27:199. [PMID: 35011433 DOI: 10.3390/molecules27010199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Liu X, Hoft DF, Peng G. Tumor microenvironment metabolites directing T cell differentiation and function. Trends Immunol 2021:S1471-4906(21)00262-3. [PMID: 34973923 DOI: 10.1016/j.it.2021.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
84 Fàbregas N, Fernie AR. The interface of central metabolism with hormone signaling in plants. Curr Biol 2021;31:R1535-48. [PMID: 34875246 DOI: 10.1016/j.cub.2021.09.070] [Reference Citation Analysis]
85 Wang XD, Kim C, Zhang Y, Rindhe S, Cobb MH, Yu Y. Cholesterol Regulates the Tumor Adaptive Resistance to MAPK Pathway Inhibition. J Proteome Res 2021;20:5379-91. [PMID: 34751028 DOI: 10.1021/acs.jproteome.1c00550] [Reference Citation Analysis]
86 Ghodousi-Dehnavi E, Hosseini RH, Arjmand M, Nasri S, Zamani Z. A Metabolomic Investigation of Eugenol on Colorectal Cancer Cell Line HT-29 by Modifying the Expression of APC, p53, and KRAS Genes. Evid Based Complement Alternat Med 2021;2021:1448206. [PMID: 34840582 DOI: 10.1155/2021/1448206] [Reference Citation Analysis]
87 Arora GK, Palamiuc L, Emerling BM. Expanding role of PI5P4Ks in cancer: A promising druggable target. FEBS Lett 2021. [PMID: 34822164 DOI: 10.1002/1873-3468.14237] [Reference Citation Analysis]
88 Huang J, Wang J, He H, Huang Z, Wu S, Chen C, Liu W, Xie L, Tao Y, Cong L, Jiang Y. Close interactions between lncRNAs, lipid metabolism and ferroptosis in cancer. Int J Biol Sci 2021;17:4493-513. [PMID: 34803512 DOI: 10.7150/ijbs.66181] [Reference Citation Analysis]
89 de Mey S, Dufait I, De Ridder M. Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures. Front Oncol 2021;11:761901. [PMID: 34778082 DOI: 10.3389/fonc.2021.761901] [Reference Citation Analysis]
90 Huang Z, Li J, Chen J, Chen D. Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer. Front Genet 2021;12:748279. [PMID: 34777473 DOI: 10.3389/fgene.2021.748279] [Reference Citation Analysis]
91 Li W, Wang X, Zhang X, Gong P, Ding D, Wang N, Wang Z. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics. Lipids Health Dis 2021;20:160. [PMID: 34774030 DOI: 10.1186/s12944-021-01572-z] [Reference Citation Analysis]
92 Mcmanus EJ, Frampton C, Tan A, Phillips MCL. Metabolics risk factors in a New Zealand glioblastoma cohort. Neuro-Oncology Practice 2022;9:43-9. [DOI: 10.1093/nop/npab064] [Reference Citation Analysis]
93 Xie B, Shi X, Li Y, Xia B, Zhou J, Du M, Xing X, Bai L, Liu E, Alvarez F, Jin L, Deng S, Mitchell GA, Pan D, Li M, Wu J. Deficiency of ASGR1 in pigs recapitulates reduced risk factor for cardiovascular disease in humans. PLoS Genet 2021;17:e1009891. [PMID: 34762653 DOI: 10.1371/journal.pgen.1009891] [Reference Citation Analysis]
94 Szlasa W, Kiełbik A, Szewczyk A, Novickij V, Tarek M, Łapińska Z, Saczko J, Kulbacka J, Rembiałkowska N. Atorvastatin Modulates the Efficacy of Electroporation and Calcium Electrochemotherapy. Int J Mol Sci 2021;22:11245. [PMID: 34681903 DOI: 10.3390/ijms222011245] [Reference Citation Analysis]
95 Zhang Y, Mao Q, Xia Q, Cheng J, Huang Z, Li Y, Chen P, Yang J, Fan X, Liang Y, Lin H. Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers. J Hematol Oncol 2021;14:169. [PMID: 34654454 DOI: 10.1186/s13045-021-01179-y] [Reference Citation Analysis]
96 Xi Y, Yani Z, Jing M, Yinhang W, Xiaohui H, Jing Z, Quan Q, Shuwen H. Mechanisms of induction of tumors by cholesterol and potential therapeutic prospects. Biomed Pharmacother 2021;144:112277. [PMID: 34624674 DOI: 10.1016/j.biopha.2021.112277] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Lee HJ, Chen Z, Collard M, Chen F, Chen JG, Wu M, Alani RM, Cheng J. Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma. BME Frontiers 2021;2021:1-17. [DOI: 10.34133/2021/9860123] [Reference Citation Analysis]
98 Kumar N, Mandal CC. Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis. Front Genet 2021;12:724149. [PMID: 34603386 DOI: 10.3389/fgene.2021.724149] [Reference Citation Analysis]
99 Sima LE, Chen S, Cardenas H, Zhao G, Wang Y, Ivan C, Huang H, Zhang B, Matei D. Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer. J Immunother Cancer 2021;9:e002682. [PMID: 34593619 DOI: 10.1136/jitc-2021-002682] [Reference Citation Analysis]
100 Yang K, Zhu J, Luo HH, Yu SW, Wang L. Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in ApcMin/+ mice. Int J Immunopathol Pharmacol 2021;35:20587384211038345. [PMID: 34586888 DOI: 10.1177/20587384211038345] [Reference Citation Analysis]
101 Škara L, Huđek Turković A, Pezelj I, Vrtarić A, Sinčić N, Krušlin B, Ulamec M. Prostate Cancer-Focus on Cholesterol. Cancers (Basel) 2021;13:4696. [PMID: 34572923 DOI: 10.3390/cancers13184696] [Reference Citation Analysis]
102 Lethongsavarn V, Pinault M, Diedhiou A, Guimaraes C, Guibon R, Bruyère F, Mathieu R, Rioux-Leclercq N, Multigner L, Brureau L, Fournier G, Doucet L, Blanchet P, Fromont G. Tissue cholesterol metabolism and prostate cancer aggressiveness: Ethno-geographic variations. Prostate 2021;81:1365-73. [PMID: 34516695 DOI: 10.1002/pros.24234] [Reference Citation Analysis]
103 Zeng W, Yin X, Jiang Y, Jin L, Liang W. PPARα at the crossroad of metabolic-immune regulation in cancer. FEBS J 2021. [PMID: 34480827 DOI: 10.1111/febs.16181] [Reference Citation Analysis]
104 Zhao S, Peralta RM, Avina-Ochoa N, Delgoffe GM, Kaech SM. Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet. Semin Immunol 2021;52:101485. [PMID: 34462190 DOI: 10.1016/j.smim.2021.101485] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Wang C, Lin T, Wang X, Yu Z, Zhuge X, Cui W, Wang M, Wang Z, Guo C, Chen X. Low high-density lipoprotein cholesterol levels are associated with malignant intraductal papillary mucinous neoplasms: A multicenter study. Lipids Health Dis 2021;20:94. [PMID: 34454509 DOI: 10.1186/s12944-021-01523-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Zhao J, Bai H, Li X, Yan J, Zou G, Wang L, Li X, Liu Z, Xiang R, Yang XL, Shi Y. Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer. Signal Transduct Target Ther 2021;6:303. [PMID: 34400610 DOI: 10.1038/s41392-021-00714-0] [Reference Citation Analysis]
107 Zou H, Yang N, Zhang X, Chen HW. RORγ is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases. Biochem Pharmacol 2021;:114725. [PMID: 34384758 DOI: 10.1016/j.bcp.2021.114725] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
108 Zhou J, Zhang S, Liu Y. Electrochemiluminescence Single‐cell Analysis on Nanostructured Interface. Electroanalysis. [DOI: 10.1002/elan.202100341] [Reference Citation Analysis]
109 Zhang Y, Chen H, Chen S, Li Z, Chen J, Li W. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. Oncoimmunology 2021;10:1957605. [PMID: 34377596 DOI: 10.1080/2162402X.2021.1957605] [Reference Citation Analysis]
110 Ershov P, Kaluzhskiy L, Mezentsev Y, Yablokov E, Gnedenko O, Ivanov A. Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context. Biomedicines 2021;9:895. [PMID: 34440098 DOI: 10.3390/biomedicines9080895] [Reference Citation Analysis]
111 Alapati K, Handanahal SS. Cytotoxic activity of cholesterol oxidase produced by Streptomyces sp. AKHSS against cancerous cell lines: mechanism of action in HeLa cells. World J Microbiol Biotechnol 2021;37:141. [PMID: 34287712 DOI: 10.1007/s11274-021-03076-5] [Reference Citation Analysis]
112 He L, Li H, Pan C, Hua Y, Peng J, Zhou Z, Zhao Y, Lin M. Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediated MAPK signaling. Cancer Commun (Lond) 2021;41:726-46. [PMID: 34268906 DOI: 10.1002/cac2.12187] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Li T, Yin Y, Zhou Z, Qiu J, Liu W, Zhang X, He K, Cai Y, Zhu ZJ. Ion mobility-based sterolomics reveals spatially and temporally distinctive sterol lipids in the mouse brain. Nat Commun 2021;12:4343. [PMID: 34267224 DOI: 10.1038/s41467-021-24672-x] [Reference Citation Analysis]
114 Andersen ME, Hagenbuch B, Apte U, Corton JC, Fletcher T, Lau C, Roth WL, Staels B, Vega GL, Clewell HJ 3rd, Longnecker MP. Why is elevation of serum cholesterol associated with exposure to perfluoroalkyl substances (PFAS) in humans? A workshop report on potential mechanisms. Toxicology 2021;459:152845. [PMID: 34246716 DOI: 10.1016/j.tox.2021.152845] [Reference Citation Analysis]
115 Kabe Y, Koike I, Yamamoto T, Hirai M, Kanai A, Furuhata R, Tsugawa H, Harada E, Sugase K, Hanadate K, Yoshikawa N, Hayashi H, Noda M, Uchiyama S, Yamazaki H, Tanaka H, Kobayashi T, Handa H, Suematsu M. Glycyrrhizin Derivatives Suppress Cancer Chemoresistance by Inhibiting Progesterone Receptor Membrane Component 1. Cancers (Basel) 2021;13:3265. [PMID: 34209885 DOI: 10.3390/cancers13133265] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Bhattacharya A, Chowdhury A, Chaudhury K, Shukla PC. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A potential multifaceted player in cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188581. [PMID: 34144130 DOI: 10.1016/j.bbcan.2021.188581] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Wang S, Fu JL, Hao HF, Jiao YN, Li PP, Han SY. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res 2021;170:105728. [PMID: 34119622 DOI: 10.1016/j.phrs.2021.105728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Choi C, Finlay DK. Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy. Stem Cell Res Ther 2021;12:320. [PMID: 34090499 DOI: 10.1186/s13287-021-02377-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Zembroski AS, Andolino C, Buhman KK, Teegarden D. Proteomic Characterization of Cytoplasmic Lipid Droplets in Human Metastatic Breast Cancer Cells. Front Oncol 2021;11:576326. [PMID: 34141606 DOI: 10.3389/fonc.2021.576326] [Reference Citation Analysis]
120 Ortiz N, Delgado-Carazo JC, Díaz C. Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells. Clin Exp Gastroenterol 2021;14:217-28. [PMID: 34103960 DOI: 10.2147/CEG.S310235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
121 Soldevilla B, López-López A, Lens-Pardo A, Carretero-Puche C, Lopez-Gonzalvez A, La Salvia A, Gil-Calderon B, Riesco-Martinez MC, Espinosa-Olarte P, Sarmentero J, Rubio-Cuesta B, Rincón R, Barbas C, Garcia-Carbonero R. Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance. Cancers (Basel) 2021;13:2634. [PMID: 34072010 DOI: 10.3390/cancers13112634] [Reference Citation Analysis]
122 Giacomini I, Gianfanti F, Desbats MA, Orso G, Berretta M, Prayer-Galetti T, Ragazzi E, Cocetta V. Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy. Front Oncol 2021;11:682911. [PMID: 34109128 DOI: 10.3389/fonc.2021.682911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Macchi C, Ferri N, Sirtori CR, Corsini A, Banach M, Ruscica M. Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact. Am J Pathol 2021;191:1385-97. [PMID: 34019847 DOI: 10.1016/j.ajpath.2021.04.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
124 Madan B, Virshup DM, Nes WD, Leaver DJ. Unearthing the Janus-face cholesterogenesis pathways in cancer. Biochem Pharmacol 2021;:114611. [PMID: 34010597 DOI: 10.1016/j.bcp.2021.114611] [Reference Citation Analysis]
125 Sharpe LJ, Coates HW, Brown AJ. Post-translational control of the long and winding road to cholesterol. J Biol Chem 2020;295:17549-59. [PMID: 33453997 DOI: 10.1074/jbc.REV120.010723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
126 Mayengbam SS, Singh A, Pillai AD, Bhat MK. Influence of cholesterol on cancer progression and therapy. Transl Oncol 2021;14:101043. [PMID: 33751965 DOI: 10.1016/j.tranon.2021.101043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
127 Yang F, Kou J, Liu Z, Li W, Du W. MYC Enhances Cholesterol Biosynthesis and Supports Cell Proliferation Through SQLE. Front Cell Dev Biol 2021;9:655889. [PMID: 33791309 DOI: 10.3389/fcell.2021.655889] [Reference Citation Analysis]
128 Grisan F, Spacci M, Paoli C, Costamagna A, Fantuz M, Martini M, Lefkimmiatis K, Carrer A. Cholesterol Activates Cyclic AMP Signaling in Metaplastic Acinar Cells. Metabolites 2021;11:141. [PMID: 33652890 DOI: 10.3390/metabo11030141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
129 Zhang L, He F, Gao L, Cong M, Sun J, Xu J, Wang Y, Hu Y, Asghar S, Hu L, Qiao H. Engineering Exosome-Like Nanovesicles Derived from Asparagus cochinchinensis Can Inhibit the Proliferation of Hepatocellular Carcinoma Cells with Better Safety Profile. Int J Nanomedicine 2021;16:1575-86. [PMID: 33664572 DOI: 10.2147/IJN.S293067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Guerra B, Recio C, Aranda-Tavío H, Guerra-Rodríguez M, García-Castellano JM, Fernández-Pérez L. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy. Front Oncol 2021;11:626971. [PMID: 33718197 DOI: 10.3389/fonc.2021.626971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
131 Siltari A, Auvinen A, Murtola TJ. Pharmacoepidemiological Evaluation in Prostate Cancer-Common Pitfalls and How to Avoid Them. Cancers (Basel) 2021;13:696. [PMID: 33572236 DOI: 10.3390/cancers13040696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
132 Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, Liang J, Tang Y, Su M, Luo X, Yang Y, Shi Y, Wang H, Zhou Y, Liao Q. The cancer metabolic reprogramming and immune response. Mol Cancer 2021;20:28. [PMID: 33546704 DOI: 10.1186/s12943-021-01316-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
133 Scully T, Ettela A, LeRoith D, Gallagher EJ. Obesity, Type 2 Diabetes, and Cancer Risk. Front Oncol 2020;10:615375. [PMID: 33604295 DOI: 10.3389/fonc.2020.615375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Matsushita Y, Nakagawa H, Koike K. Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat. Cancers (Basel) 2021;13:474. [PMID: 33530546 DOI: 10.3390/cancers13030474] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 28.0] [Reference Citation Analysis]
135 Schirris TJJ, Rossell S, de Haas R, Frambach SJCM, Hoogstraten CA, Renkema GH, Beyrath JD, Willems PHGM, Huynen MA, Smeitink JAM, Russel FGM, Notebaart RA. Stimulation of cholesterol biosynthesis in mitochondrial complex I-deficiency lowers reductive stress and improves motor function and survival in mice. Biochim Biophys Acta Mol Basis Dis 2021;1867:166062. [PMID: 33385517 DOI: 10.1016/j.bbadis.2020.166062] [Reference Citation Analysis]
136 Codini M, Garcia-Gil M, Albi E. Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer. Int J Mol Sci 2021;22:E726. [PMID: 33450869 DOI: 10.3390/ijms22020726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
137 Gil-Hernández A, Arroyo-Campuzano M, Simoni-Nieves A, Zazueta C, Gomez-Quiroz LE, Silva-Palacios A. Relevance of Membrane Contact Sites in Cancer Progression. Front Cell Dev Biol 2020;8:622215. [PMID: 33511135 DOI: 10.3389/fcell.2020.622215] [Reference Citation Analysis]
138 Juarez D, Fruman DA. Targeting the Mevalonate Pathway in Cancer. Trends Cancer 2021;7:525-40. [PMID: 33358111 DOI: 10.1016/j.trecan.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
139 Karstensen KT, Schein A, Petri A, Bøgsted M, Dybkær K, Uchida S, Kauppinen S. Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma. Noncoding RNA 2020;7:1. [PMID: 33379241 DOI: 10.3390/ncrna7010001] [Reference Citation Analysis]
140 Ehmsen S, Ditzel HJ. Signaling pathways essential for triple-negative breast cancer stem-like cells. Stem Cells 2021;39:133-43. [PMID: 33211379 DOI: 10.1002/stem.3301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
141 Varan G, Akkın S, Demirtürk N, Benito JM, Bilensoy E. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver. J Drug Target 2021;29:439-53. [PMID: 33210947 DOI: 10.1080/1061186X.2020.1853743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Di Virgilio F, Vultaggio-Poma V, Sarti AC. P2X receptors in cancer growth and progression. Biochem Pharmacol 2021;187:114350. [PMID: 33253643 DOI: 10.1016/j.bcp.2020.114350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Revilla G, Cedó L, Tondo M, Moral A, Pérez JI, Corcoy R, Lerma E, Fuste V, Reddy ST, Blanco-Vaca F, Mato E, Escolà-Gil JC. LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies. Semin Cancer Biol 2021;73:134-57. [PMID: 33249202 DOI: 10.1016/j.semcancer.2020.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Lee JS, Kim HY, Won B, Kang SW, Kim YN, Jang H. SEZ6L2 Is an Important Regulator of Drug-Resistant Cells and Tumor Spheroid Cells in Lung Adenocarcinoma. Biomedicines 2020;8:E500. [PMID: 33202873 DOI: 10.3390/biomedicines8110500] [Reference Citation Analysis]
145 Cokan KB, Urlep Ž, Lorbek G, Matz-Soja M, Skubic C, Perše M, Jeruc J, Juvan P, Režen T, Rozman D. Chronic Disruption of the Late Cholesterol Synthesis Leads to Female-Prevalent Liver Cancer. Cancers (Basel) 2020;12:E3302. [PMID: 33182326 DOI: 10.3390/cancers12113302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Qiu J, Li T, Zhu ZJ. Multi-dimensional characterization and identification of sterols in untargeted LC-MS analysis using all ion fragmentation technology. Anal Chim Acta 2021;1142:108-17. [PMID: 33280688 DOI: 10.1016/j.aca.2020.10.058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
147 Dumitru AC, Mohammed D, Maja M, Yang J, Verstraeten S, Del Campo A, Mingeot-Leclercq MP, Tyteca D, Alsteens D. Label-Free Imaging of Cholesterol Assemblies Reveals Hidden Nanomechanics of Breast Cancer Cells. Adv Sci (Weinh) 2020;7:2002643. [PMID: 33240781 DOI: 10.1002/advs.202002643] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
148 Pellerin L, Carrié L, Dufau C, Nieto L, Ségui B, Levade T, Riond J, Andrieu-Abadie N. Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers (Basel) 2020;12:E3147. [PMID: 33121001 DOI: 10.3390/cancers12113147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
149 Sun L, Ji X, Wang D, Guan A, Xiao Y, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. Integrated analysis of serum lipid profile for predicting clinical outcomes of patients with malignant biliary tumor. BMC Cancer 2020;20:980. [PMID: 33036576 DOI: 10.1186/s12885-020-07496-8] [Reference Citation Analysis]
150 Iannelli F, Roca MS, Lombardi R, Ciardiello C, Grumetti L, De Rienzo S, Moccia T, Vitagliano C, Sorice A, Costantini S, Milone MR, Pucci B, Leone A, Di Gennaro E, Mancini R, Ciliberto G, Bruzzese F, Budillon A. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition. J Exp Clin Cancer Res 2020;39:213. [PMID: 33032653 DOI: 10.1186/s13046-020-01723-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
151 Ortiz N, Díaz C. Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer. Oncol Lett 2020;20:320. [PMID: 33093924 DOI: 10.3892/ol.2020.12183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Andersen CB, Runge Walther A, Pipó-Ollé E, Notabi MK, Juul S, Eriksen MH, Lovatt AL, Cowie R, Linnet J, Kobaek-Larsen M, El-Houri R, Andersen MØ, Hedegaard MAB, Christensen LP, Arnspang EC. Falcarindiol Purified From Carrots Leads to Elevated Levels of Lipid Droplets and Upregulation of Peroxisome Proliferator-Activated Receptor-γ Gene Expression in Cellular Models. Front Pharmacol 2020;11:565524. [PMID: 32982759 DOI: 10.3389/fphar.2020.565524] [Reference Citation Analysis]
153 Choi C, Finlay DK. Diverse Immunoregulatory Roles of Oxysterols-The Oxidized Cholesterol Metabolites. Metabolites 2020;10:E384. [PMID: 32998240 DOI: 10.3390/metabo10100384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
154 Sunami Y. NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling. Int J Mol Sci 2020;21:E6799. [PMID: 32947972 DOI: 10.3390/ijms21186799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
155 Gómez-Coronado D, Lasunción MA, Martínez-Botas J, Fernández-Suárez ME. Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators. Semin Cancer Biol 2021;73:101-15. [PMID: 32931953 DOI: 10.1016/j.semcancer.2020.08.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
156 de Medina P, Diallo K, Huc-Claustre E, Attia M, Soulès R, Silvente-Poirot S, Poirot M. The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets. Br J Pharmacol 2021;178:3248-60. [PMID: 32696532 DOI: 10.1111/bph.15205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
157 Bleve A, Durante B, Sica A, Consonni FM. Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad. Int J Mol Sci 2020;21:E5845. [PMID: 32823961 DOI: 10.3390/ijms21165845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
158 Hall Z, Wilson CH, Burkhart DL, Ashmore T, Evan GI, Griffin JL. Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancer. J Lipid Res 2020;61:1390-9. [PMID: 32753459 DOI: 10.1194/jlr.RA120000899] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Shyer JA, Flavell RA, Bailis W. Metabolic signaling in T cells. Cell Res 2020;30:649-59. [PMID: 32709897 DOI: 10.1038/s41422-020-0379-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
160 Xu H, Zhou S, Tang Q, Xia H, Bi F. Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer 2020;1874:188394. [PMID: 32698040 DOI: 10.1016/j.bbcan.2020.188394] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 30.0] [Reference Citation Analysis]
161 Fahim SA, Abdullah MS, Espinoza-Sánchez NA, Hassan H, Ibrahim AM, Ahmed SH, Shakir G, Badawy MA, Zakhary NI, Greve B, El-Shinawi M, Götte M, Ibrahim SA. Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value. Biomolecules 2020;10:E1059. [PMID: 32708601 DOI: 10.3390/biom10071059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
162 Chua NK, Coates HW, Brown AJ. Squalene monooxygenase: a journey to the heart of cholesterol synthesis. Progress in Lipid Research 2020;79:101033. [DOI: 10.1016/j.plipres.2020.101033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
163 Chang YC, Liu HQ, Chang JH, Chang YY, Lin EC. Role of the cholesterol hydroxyl group in the chemical exchange saturation transfer signal at -1.6 ppm. NMR Biomed 2020;33:e4356. [PMID: 32575161 DOI: 10.1002/nbm.4356] [Reference Citation Analysis]
164 [DOI: 10.1101/2020.07.12.198903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]